-
P661596-1ml(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1. PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha ( ERRa ) binding group. PROTAC ERRα Degrader-1 is an
-
R658774-10mg(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1. PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha ( ERRa ) binding group. PROTAC ERRα Degrader-1 is an
-
R658774-1mg(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1. PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha ( ERRa ) binding group. PROTAC ERRα Degrader-1 is an
-
R658774-5mg(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1. PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha ( ERRa ) binding group. PROTAC ERRα Degrader-1 is an
-
R287510-10mg(RS)-(Tetrazol-5-yl)glycine.
-
R287510-50mg(RS)-(Tetrazol-5-yl)glycine.
-
R611152-25mg(RS)-(tetrazol-5-yl)glycine.
-
R611152-5mg(RS)-(tetrazol-5-yl)glycine.
-
R287507-100mg(RS)-3,4-DCPG.
-
-
-